Effects of Chardonnay Seed Flour on Vascular Health
NCT02093455 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 168
Last updated 2022-02-11
Summary
This is a randomized, double-blinded trial (Chardonnay seed flour vs. placebo - in pill form) with the purpose to test the impact of a four-month supplementation with Chardonnay Seed Flour (CSF) on endothelial function. Chardonnay flour is made from wine grape skins and seeds. We will examine the effect of CSF on parameters such as endothelial function (via EndoPAT testing), plasma lipid levels, glucose tolerance, insulin resistance, inflammatory markers, oxidative stress surrogates, endothelial progenitor cells (EPCs) as well as the makeup of and impact on the gut microbiome (via stool samples).
Conditions
- 1. Endothelial Dysfunction (EndoPAT Score <=2)
Interventions
- DIETARY_SUPPLEMENT
-
Chardonnay Seed Flour (CSF)
CSF is made from wine grape skins and seeds.
- DIETARY_SUPPLEMENT
-
Placebo
Sponsors & Collaborators
-
Whole Vine Products
collaborator UNKNOWN - lead OTHER
Principal Investigators
-
Amir Lerman, MD · Mayo Clinic
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-03-31
- Primary Completion
- 2017-08-23
- Completion
- 2017-08-23
Countries
- United States
Study Locations
More Related Trials
-
A Strategy for Gallstone Expulsion Through Dietary Therapy
NCT06699030 ·Status: RECRUITING ·Phase: NA
-
Phase II Study of Cholesterol- and Cholestanol-Free Diet, Lovastatin, and Chenodeoxycholic Acid for Cerebrotendinous Xanthomatosis
NCT00004346 ·Status: UNKNOWN ·Phase: PHASE2
-
Slowly Digestible Carbohydrates and the Ileal Brake
NCT03630445 ·Status: COMPLETED ·Phase: NA
-
Dietary Glycine Supplementation in Metabolic Dysfunction-associated Steatotic Liver Disease
NCT07285135 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Intralumenal Effects on Cholesterol Absorption/Synthesis
NCT00328211 ·Status: COMPLETED ·Phase: NA
-
Selenium Supplementation of Patients With Cirrhosis
NCT00271245 ·Status: TERMINATED ·Phase: NA
-
Clinical Food Study to Evaluate the Effect of KB174 on the Gut Microbiome in Subjects With Well-compensated Cirrhosis
NCT03855956 ·Status: COMPLETED ·Phase: NA
-
Migalastat Food Effect Study
NCT01489995 ·Status: COMPLETED ·Phase: PHASE1
-
Pilot Study To Assess CAT-2003 in Patients With Chylomicronemia
NCT02098278 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Epicatechin on Functional Capacity, Skeletal Muscle Structure and Diastolic Function in Patients With Heart Failure With Preserved Ejection Fraction (HFPEF)
NCT02068040 ·Status: COMPLETED ·Phase: NA
-
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
NCT06425380 ·Status: RECRUITING ·Phase: NA
-
Injection Techniques of Collagenase Clostridium Histolyticum (CCH) for the Treatment of EFP (Cellulite)
NCT03632993 ·Status: COMPLETED ·Phase: PHASE2
-
Chia Supplementation and Non Alcoholic Fatty Liver Disease
NCT03942822 ·Status: COMPLETED ·Phase: NA
-
A Trial of Taurine Supplementation in Parenteral Nutrition 1
NCT00135044 ·Status: UNKNOWN ·Phase: NA
-
The Use of High Bile-binding Foods to Reduce Upper Gastrointestinal Bile Acid Concentrations (Aim 2)
NCT07303868 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Clinical Study on the Safety of CNT-02 for TGCV and NLSD-M
NCT02830763 ·Status: TERMINATED ·Phase: NA
-
Alleviation Of Metabolic Endotoxemia In Adults With Metabolic Syndrome With Milk Fat Globule Membrane
NCT03860584 ·Status: COMPLETED ·Phase: NA
-
Gastric Emptying and Gallbladder Motility Study
NCT00940849 ·Status: COMPLETED ·Phase: NA
-
Vitamin E Dosing Study
NCT04801849 ·Status: COMPLETED ·Phase: PHASE2
-
Phase I Clinical Study of Chondroitin Sulfate for Treatment of NEC
NCT06547424 ·Status: WITHDRAWN ·Phase: PHASE1
-
Bovine Colostrum for Patients With Non Alcoholic Fatty Liver Disease
NCT01016418 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of Chenodeoxycholic Acid (CDCA) in Newly Diagnosed Participants With Cerebrotendinous Xanthomatosis (CTX)
NCT06260748 ·Status: WITHDRAWN ·Phase: PHASE3
-
Study to Evaluate Efficacy, Safety and Tolerability of PENNEL Capsule in the Patients With Chronic Liver Disease
NCT01393665 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Tolerance of Treatment With DHA, Choline and Vitamin E in Children With Non-alcoholic Steatohepatitis
NCT01934777 ·Status: COMPLETED ·Phase: PHASE3
-
THE IMMUNOLOGICAL EFFECTS AND METABOLIC TOLERANCE OF LIPID INFUSION IN PATIENTS WITH CIRRHOSIS.
NCT02381769 ·Status: COMPLETED ·Phase: NA